February 1, 2023
A Japanese health ministry panel will discuss approval for two regenerative medicine products at its meeting on February 13 including Japan Tissue Engineering’s (J-TEC) autologous cell sheet for the treatment of stable vitiligo. The J-TEC product is autologous cultured epidermis...read more